Evaluation of Alzheimer's disease biomarkers and cognition in non‐Hispanic Black and non‐Hispanic White participants in ADNI and US POINTER Imaging

NHBs had lower Aβ and EC tau than NHWs in POINTER but not ADNI, and there were inconsistent associations between Aβ and EC tau across cohorts. Despite these differences, AD biomarkers appear similarly related to cognitive outcomes across ethnoracial groups in both cohorts. Future analyses will attempt to further determine the generalizability of AD biomarker relationships in diverse samples by considering matching on relevant health and demographic characteristics, and inclusion of additional cohorts with harmonized biomarker and cognitive measurements.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_100136
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of Alzheimer's disease biomarkers and cognition in non‐Hispanic Black and non‐Hispanic White participants in ADNI and US POINTER Imaging

Heather M. Snyder, Laura D. Baker, Talia L. Robinson, Theresa M. Harrison et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Evaluation of Alzheimer's disease biomarkers and cognition in non‐Hispanic Black and non‐Hispanic White participants in ADNI and US POINTER Imaging

Heather M. Snyder, Laura D. Baker, Talia L. Robinson, Theresa M. Harrison, Rebecca England Amariglio, Susan M. Landau, Alzheimer's Disease Neuroimaging Initiative US POINTER Study Group, Charles S. DeCarli, Kathryn V Papp, Prashanthi Vemuri
article en

Abstract

NHBs had lower Aβ and EC tau than NHWs in POINTER but not ADNI, and there were inconsistent associations between Aβ and EC tau across cohorts. Despite these differences, AD biomarkers appear similarly related to cognitive outcomes across ethnoracial groups in both cohorts. Future analyses will attempt to further determine the generalizability of AD biomarker relationships in diverse samples by considering matching on relevant health and demographic characteristics, and inclusion of additional cohorts with harmonized biomarker and cognitive measurements.

Alzheimer s & DementiaVol. 21(S2)
Alzheimer's Association (US), Brigham and Women's Hospital (US), Massachusetts General Hospital (US), Mayo Clinic in Arizona (US), Wake Forest University (US), University of California, Davis (US), University of California, Berkeley (US)
Quality Education
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evaluation of Alzheimer's disease biomarkers and cognition in non‐Hispanic Black and non‐Hispanic White participants in ADNI and US POINTER Imaging — Heather M. Snyder, Laura D. Baker, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS